| Literature DB >> 27089112 |
D Dubey1, E Golden, A Suss, C A Cano, G Krishnan, O Stuve.
Abstract
Entities:
Mesh:
Substances:
Year: 2016 PMID: 27089112 PMCID: PMC4944349 DOI: 10.4103/0022-3859.180577
Source DB: PubMed Journal: J Postgrad Med ISSN: 0022-3859 Impact factor: 1.476
Figure 1Serial brain MRI scans of the patient. First MRI of brain on presentation showed gadolinium-enhancing lesions (a and b) and a T2 hyperintense lesions with perilesional hypontense rim (c). Second MRI of brain obtained prior to initiation of plasmapheresis showed minimal enlargement of the contrast-enhancing lesion (d)